Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review

Link to article at PubMed

World J Gastroenterol. 2020 Sep 14;26(34):5060-5073. doi: 10.3748/wjg.v26.i34.5060.


Budd-Chiari syndrome (BCS) is a relatively rare clinical condition with a wide range of symptomatology, caused by the obstruction of the hepatic venous outflow. If left untreated, it has got an high mortality rate. Its management is based on a step-wise approach, depending on the clinical presentation, and includes different treatment from anticoagulation therapy up to Interventional Radiology techniques, such as transjugular intrahepatic portosystemic shunt (TIPS). TIPS is today considered a safe and highly effective treatment and should be recommended for BCS patients, including those awaiting orthotopic liver transplantation. In this review the pathophysiology, diagnosis and treatment options of BCS are presented, with a special focus on published data regarding the techniques and outcomes of TIPS for the treatment of BCS. Moreover, unresolved issues and future research will be discussed.

PMID:32982109 | PMC:PMC7495032 | DOI:10.3748/wjg.v26.i34.5060

Leave a Reply

Your email address will not be published. Required fields are marked *